Melanocortin ligands: 30 years of structure–activity relationship (SAR) studies
暂无分享,去创建一个
[1] P. Prusis,et al. Selectivity of Cyclic [d-Nal7] and [d-Phe7] Substituted MSH Analogues for the Melanocortin Receptor Subtypes , 1997, Peptides.
[2] V. Hruby,et al. Cyclic lactam analogues of Ac-[Nle4]alpha-MSH4-11-NH2. , 1988, Biochemistry.
[3] G. Barsh,et al. Effects of recombinant agouti-signaling protein on melanocortin action. , 1997, Molecular endocrinology.
[4] R. Cone,et al. A Unique Metalolic Sysdrone Causes Obesity in the Melanocortin-3 Receptor-Deficient Mouse. , 2000, Endocrinology.
[5] P. Grieco,et al. Synthesis and biological evaluation on hMC3, hMC4 and hMC5 receptors of gamma-MSH analogs substituted with L-alanine. , 2002, The journal of peptide research : official journal of the American Peptide Society.
[6] V. Hruby,et al. Chapter 30. Recent Progress in the Rational Design of Peptide Hormones and Neurotransmitters , 1984 .
[7] V. Hruby,et al. Structure‐Activity Relationships of [Nle4, D‐Phe7]α‐MSH , 1993 .
[8] J. Deshusses,et al. Synthesis and characterization of an acylated di-peptide (Myr-Trp-Leu) with modified transmucosal transport properties. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[9] Y. Lee,et al. A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. , 2002, The Journal of clinical endocrinology and metabolism.
[10] I. Jackson,et al. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. , 1996, Human molecular genetics.
[11] G. Barsh,et al. Genetic studies of the mouse mutations mahogany and mahoganoid. , 1997, Genetics.
[12] H. Schiöth,et al. Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. , 2002, The Journal of investigative dermatology.
[13] P. Bork,et al. The mahogany protein is a receptor involved in suppression of obesity , 1999, Nature.
[14] R. Cone. The Melanocortin Receptors , 2000, The Receptors.
[15] R. Cone. Melanocortin Receptors, The , 2000 .
[16] V J Hruby,et al. Design of peptides, proteins, and peptidomimetics in chi space. , 1997, Biopolymers.
[17] J. Baik,et al. Type I beta-turn conformation is important for biological activity of the melanocyte-stimulating hormone analogues. , 1999, European journal of biochemistry.
[18] V. Hruby,et al. Conformational and topographical considerations in the design of biologically active peptides , 1993, Biopolymers.
[19] R. Seeley,et al. A Novel Selective Melanocortin-4 Receptor Agonist Reduces Food Intake in Rats and Mice without Producing Aversive Consequences , 2000, The Journal of Neuroscience.
[20] S. Watson,et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. , 1993, The Journal of biological chemistry.
[21] J. Weiel,et al. Agouti structure and function: characterization of a potent alpha-melanocyte stimulating hormone receptor antagonist. , 1995, Biochemistry.
[22] M. Bednarek,et al. Analogs of MTII, lactam derivatives of alpha-melanotropin, modified at the N-terminus, and their selectivity at human melanocortin receptors 3, 4, and 5. , 1999, Biochemical and biophysical research communications.
[23] H. Schiöth. The physiological role of melanocortin receptors. , 2001, Vitamins and hormones.
[24] A. Turnbull,et al. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. , 2002, The Journal of endocrinology.
[25] Ronald W. Davis,et al. The mouse mahogany locus encodes a transmembrane form of human attractin , 1999, Nature.
[26] T. Luger,et al. The Role of Melanocortins in Skin Homeostasis , 2001, Hormone Research in Paediatrics.
[27] K. Georgeson,et al. Molecular Determinants of Human Melanocortin-4 Receptor Responsible for Antagonist SHU9119 Selective Activity* , 2002, The Journal of Biological Chemistry.
[28] V. Hruby,et al. [half-Cys4,half-Cys10]-alpha-Melanocyte-stimulating hormone: a cyclic alpha-melanotropin exhibiting superagonist biological activity. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[29] V J Hruby,et al. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R. , 1997, Journal of medicinal chemistry.
[30] T. Fitzpatrick,et al. In vitro bioassay for the melanocyte stimulating hormone. , 1954, Endocrinology.
[31] J. Tokarski,et al. Discovery of tyrosine-based potent and selective melanocortin-1 receptor small-molecule agonists with anti-inflammatory properties. , 2003, Journal of medicinal chemistry.
[32] M. Bednarek,et al. Selective, high affinity peptide antagonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro. , 2001, Journal of medicinal chemistry.
[33] G. Barsh,et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.
[34] C. Haskell-Luevano,et al. Urea small molecule agonists on mouse melanocortin receptors. , 2003, Bioorganic & medicinal chemistry letters.
[35] M. Mortrud,et al. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[36] Reductive amination products containing naphthalene and indole moieties bind to melanocortin receptors. , 2002, Bioorganic & medicinal chemistry letters.
[37] Victor J. Hruby,et al. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome , 1997, Nature.
[38] J. Cheetham,et al. Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: antagonists for the AGRP/melanocortin receptor binding. , 2003, Journal of medicinal chemistry.
[39] Xin-jie Chu,et al. Structure-activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH(2) at the human melanocortin-1 and -4 receptors: histidine substitution. , 2002, Bioorganic & medicinal chemistry letters.
[40] L. Lundin,et al. Val92Met variant of the melanocyte stimulating hormone receptor gene , 1996, Nature Genetics.
[41] J. Wikberg,et al. Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. , 1999, Biochemical and biophysical research communications.
[42] V. Hruby,et al. Design, Synthesis, and Conformation of Superpotent and Prolonged Acting Melanotropins a , 1993, Annals of the New York Academy of Sciences.
[43] V. Hruby,et al. beta-Methylation of the Phe7 and Trp9 melanotropin side chain pharmacophores affects ligand-receptor interactions and prolonged biological activity. , 1997, Journal of medicinal chemistry.
[44] D. I. Våge,et al. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. , 1996, Recent progress in hormone research.
[45] C. Haskell-Luevano,et al. Structure–activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 at the mouse melanocortin receptors Part 3: modifications at the Arg position , 2003, Peptides.
[46] W. Sterry,et al. New treatment modalities for basal cell carcinoma. , 2002, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[47] M. Mihm,et al. ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. , 1996, The Journal of clinical endocrinology and metabolism.
[48] R. Cone,et al. Structure activity studies of the melanocortin antagonist SHU9119 modified at the 6, 7, 8, and 9 positions☆ , 2000, Peptides.
[49] C. Humblet,et al. Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists. , 1996, Drug design and discovery.
[50] V. Hruby,et al. Topographically designed analogues of [D-Pen,D-Pen5]enkephalin. , 1991, Journal of medicinal chemistry.
[51] C. Beglinger,et al. A combinatorial peptoid library for the identification of novel MSH and GRP/bombesin receptor ligands. , 1999, Journal of receptor and signal transduction research.
[52] A. Lerner,et al. On the movement of pigment granules in frog melanocytes. , 1960, Endocrinology.
[53] J. M. Lipton,et al. The Neuroimmunomodulatory Peptide α‐MSH , 2000 .
[54] I. Gantz,et al. Molecular Basis for the Interaction of [Nle4,d-Phe7]Melanocyte Stimulating Hormone with the Human Melanocortin-1 Receptor (Melanocyte α-MSH Receptor)* , 1997, The Journal of Biological Chemistry.
[55] C. Haskell-Luevano,et al. Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors. , 2001, Journal of medicinal chemistry.
[56] V. Slepnev,et al. Fatty acid acylated peroxidase as a model for the study of interactions of hydrophobically-modified proteins with mammalian cells. , 1995, Bioconjugate chemistry.
[57] Yue Feng,et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass , 2000, Nature Genetics.
[58] Z. Abdel‐Malek. Melanocortin receptors: their functions and regulation by physiological agonists and antagonists , 2001, Cellular and Molecular Life Sciences CMLS.
[59] R. Cone,et al. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. , 1996, Endocrinology.
[60] C. Grunfeld,et al. Characterization of adrenocorticotropin receptors that appear when 3T3-L1 cells differentiate into adipocytes. , 1985, Endocrinology.
[61] V. Hruby,et al. Quantitative determination of amino acid racemization in heat--alkali-treated melanotropins: implications for peptide hormone structure--function studies. , 1981, Analytical biochemistry.
[62] J. Shutter,et al. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. , 1997, Genes & development.
[63] V. Hruby,et al. The Molecular Pharmacology of Alpha-Melanocyte Stimulating Hormone: Structure-Activity Relationships for Melanotropins at Melanocortin Receptors , 2000 .
[64] V. Hruby,et al. Enzymological studies of melanotropins. , 1984, Comparative biochemistry and physiology. B, Comparative biochemistry.
[65] M. Meldal,et al. A solid-phase approach to mouse melanocortin receptor agonists derived from a novel thioether cyclized peptidomimetic scaffold. , 2002, Journal of the American Chemical Society.
[66] R. Woychik,et al. Molecular characterization of the mouse agouti locus , 1992, Cell.
[67] V. Hruby,et al. Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations. , 1990, The Biochemical journal.
[68] V. Hruby,et al. α-Melanocyte stimulating hormone message and inhibitory sequences: Comparative structure-activity studies on melanocytes , 1990, Peptides.
[69] S. O’Rahilly,et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity , 1998, Nature Genetics.
[70] Ximena Opitz-Araya,et al. Exocrine Gland Dysfunction in MC5-R-Deficient Mice: Evidence for Coordinated Regulation of Exocrine Gland Function by Melanocortin Peptides , 1997, Cell.
[71] J. Hebebrand,et al. Candidate gene polymorphisms in eating disorders. , 2000, European journal of pharmacology.
[72] G. Landis,et al. Ring substituted and other conformationally constrained tyrosine analogues of [D-Pen2,D-Pen5]enkephalin with delta opioid receptor selectivity. , 1992, Journal of medicinal chemistry.
[73] N. R. Douglas,et al. Peptoid mimics of agouti related protein. , 2003, Bioorganic & medicinal chemistry letters.
[74] L. Gantert,et al. Activation of melanocortin MC(4) receptors increases erectile activity in rats ex copula. , 2002, European journal of pharmacology.
[75] V. Hruby,et al. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[76] R. Cone,et al. Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.
[77] V. Hruby,et al. Characterizations of the unusual dissociation properties of melanotropin peptides from the melanocortin receptor, hMC1R. , 1996, Journal of medicinal chemistry.
[78] P. Prusis,et al. Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist , 1999, British journal of pharmacology.
[79] M. Bednarek,et al. 1H‐NMR studies on a potent and selective antagonist at human melanocortin receptor 4 (hMC‐4R) , 2003, Biopolymers.
[80] V. Hruby,et al. Biological activities of melanotropic peptide fatty acid conjugates. , 1991, Pigment cell research.
[81] V. Hruby,et al. Structure and dynamics of α-MSH using DRISM integral equation theory and stochastic dynamics , 1999 .
[82] T K Sawyer,et al. Alpha-melanotropin: the minimal active sequence in the lizard skin bioassay. , 1989, General and comparative endocrinology.
[83] T. Luger,et al. The Role of α‐MSH as a Modulator of Cutaneous Inflammation , 2000 .
[84] B. Pettitt,et al. Modeling of alpha-MSH conformations with implicit solvent. , 1999, The journal of peptide research : official journal of the American Peptide Society.
[85] R. Cone,et al. Compounds that activate the mouse melanocortin-1 receptor identified by screening a small molecule library based upon the beta-turn. , 1999, Journal of medicinal chemistry.
[86] H. Bundgaard,et al. Prodrugs of Peptides. 6. Bioreversible Derivatives of Thyrotropin-Releasing Hormone (TRH) with Increased Lipophilicity and Resistance to Cleavage by the TRH-Specific Serum Enzyme , 1990, Pharmaceutical Research.
[87] Richard P. Woychik,et al. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor , 1994, Nature.
[88] S. Lande. Racemization of a-melanotropin , 1971 .
[89] H. Bundgaard,et al. Prodrugs of peptides. IV: Bioreversible derivatization of the pyroglutamyl group by N-acylation and N-aminomethylation to effect protection against pyroglutamyl aminopeptidase. , 1989, Journal of pharmaceutical sciences.
[90] V. Hruby,et al. Synthesis and biological activities of fatty acid conjugates of a cyclic lactam alpha-melanotropin. , 1992, Journal of medicinal chemistry.
[91] M. Mortrud,et al. The cloning of a family of genes that encode the melanocortin receptors. , 1992, Science.
[92] Hongmao Sun,et al. Highly Selective Cyclic Peptides for Human Melanocortin-4 Receptor (MC-4 R): Design, Synthesis, Bioactive Conformation, and Pharmacological Evaluation as an Anti-Obesity Agent , 2001 .
[93] W. Chung,et al. The mouse mahoganoid coat color mutation disrupts a novel C3HC4 RING domain protein. , 2002, The Journal of clinical investigation.
[94] D. Cross-Doersen,et al. Synthesis of 2,4,5-trisubstituted tetrahydropyrans as peptidomimetic scaffolds for melanocortin receptor ligands. , 2003, Organic letters.
[95] M. Linder,et al. Signalling functions of protein palmitoylation. , 1998, Biochimica et biophysica acta.
[96] M. Lerner,et al. Discovery and structure-function analysis of alpha-melanocyte-stimulating hormone antagonists. , 1994, The Journal of biological chemistry.
[97] Victor J. Hruby,et al. D-amino acid scan of γ-melanocyte-stimulating hormone : Importance of Trp8 on human MC3 receptor selectivity , 2000 .
[98] P. Grieco,et al. Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6. , 2002, Biochemical and biophysical research communications.
[99] D. Johnston,et al. Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist. , 2002, Journal of medicinal chemistry.
[100] M. Bednarek,et al. Structure-function studies on the cyclic peptide MT-II, lactam derivative of α-melanotropin☆ ☆ Throughout this report, the numbering of the amino acid residues in α-MSH has been retained for all linear and cyclic peptides. , 1999, Peptides.
[101] H. Schiöth,et al. Novel selective melanocortin 4 receptor antagonist induces food intake after peripheral administration. , 2003, Biochemical and biophysical research communications.
[102] D. Sargent,et al. Membrane lipid phase as catalyst for peptide-receptor interactions. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[103] Robert Fredriksson,et al. One melanocortin 4 and two melanocortin 5 receptors from zebrafish show remarkable conservation in structure and pharmacology , 2002, Journal of neurochemistry.
[104] Paolo Grieco,et al. Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors. , 2002, Journal of medicinal chemistry.
[105] V. Hruby,et al. Design, Synthesis, Biology, and Conformations of Bicyclic α-Melanotropin Analogues , 1995 .
[106] R. Horváth,et al. Newly discovered stereochemical requirements in the side-chain conformation of delta opioid agonists for recognizing opioid delta receptors. , 1994, Journal of medicinal chemistry.
[107] V. Hruby,et al. Synthesis and biological actions of highly potent and prolonged acting biotin-labeled melanotropins. , 1984, Journal of medicinal chemistry.
[108] T. Luger,et al. Expression of melanocortin‐1 receptor in normal, malformed and neoplastic skin glands and hair follicles , 2002, Experimental dermatology.
[109] K. Kopple,et al. Reverse Turns in Peptides and Protein , 1980 .
[110] T. H. Lee,et al. On the mechanism of sodium hydroxide modification of alpha-melanocyte-stimulating hormone. , 1963, The Journal of biological chemistry.
[111] V. Hruby,et al. Truncation studies of α-melanotropin peptides identify tripeptide analogues exhibiting prolonged agonist bioactivity , 1996, Peptides.
[112] J. Bolognia,et al. The melanocortin-1 receptor: red hair and beyond. , 2001, Archives of dermatology.
[113] S. McGurk,et al. Ligand-dependent activation of the melanocortin 5 receptor: cAMP production and ryanodine receptor-dependent elevations of [Ca(2+)](I). , 2002, Biochemical and Biophysical Research Communications - BBRC.
[114] T. Glover,et al. Localization of the genes encoding the melanocortin-2 (adrenocorticotropic hormone) and melanocortin-3 receptors to chromosomes 18p11.2 and 20q13.2-q13.3 by fluorescence in situ hybridization. , 1993, Genomics.
[115] M. Mortrud,et al. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. , 1994, Molecular endocrinology.
[116] J. Wikberg,et al. Molecular cloning of a novel human melanocortin receptor. , 1993, Biochemical and biophysical research communications.
[117] E. Coutinho,et al. Comparative conformational studies on cyclic hexapeptides corresponding to message sequence His-Phe-Arg-Trp of alpha-melanotropin by NMR. , 2009, The journal of peptide research : official journal of the American Peptide Society.
[118] F. Moore,et al. α-Melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury , 2002 .
[119] H. Süli‐Vargha,et al. Synthesis and biological activity of cyclic melanotropin peptides , 1991 .
[120] Huiling He,et al. Gene expression analysis of glucocorticoid-induced apoptosis by a gene microarray technique , 2001, Nature Genetics.
[121] S. Watson,et al. Molecular cloning of a novel melanocortin receptor. , 1993, The Journal of biological chemistry.
[122] V J Hruby,et al. alpha-Melanotropin: the minimal active sequence in the frog skin bioassay. , 1987, Journal of medicinal chemistry.
[123] V. Hruby,et al. Synthesis and Biological Evaluation of the Superagonist [Nα-Chlorotriazinylaminofluorescein-Ser1, Nle4, D-Phe7]-α-MSH , 1985 .
[124] A. Lomize,et al. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13). , 1994, Journal of medicinal chemistry.
[125] P. Prusis,et al. Discovery of novel melanocortin4 receptor selective MSH analogues , 1998, British journal of pharmacology.
[126] D. H. Lee,et al. 2,3-Diaryl-5-anilino[1,2,4]thiadiazoles as melanocortin MC4 receptor agonists and their effects on feeding behavior in rats. , 2003, Bioorganic & medicinal chemistry.
[127] V. Hruby,et al. Conformational and dynamic considerations in peptide structure-function studies , 1982, Peptides.
[128] R. Nagaraj,et al. Interaction of a hydrophobic model peptide and its fatty acid derivative with lipid vesicles , 1988, FEBS letters.
[129] M. Tota,et al. ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. , 1997, Biochemical and biophysical research communications.
[130] V. Hruby,et al. Topographical modification of melanotropin peptide analogues with beta-methyltryptophan isomers at position 9 leads to differential potencies and prolonged biological activities. , 1995, Journal of Medicinal Chemistry.
[131] G. Barsh,et al. Transgenic Expression of Syndecan-1 Uncovers a Physiological Control of Feeding Behavior by Syndecan-3 , 2001, Cell.
[132] D. I. Våge,et al. A ligand-mimetic model for constitutive activation of the melanocortin-1 receptor. , 1998, Molecular endocrinology.
[133] C. Pouton,et al. Influence of α-MSH terminal amino acids on binding affinity and biological activity in melanoma cells , 1994, Peptides.
[134] K. Clément,et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. , 2000, The Journal of clinical investigation.
[135] V. Hruby,et al. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors. , 1997, Journal of medicinal chemistry.
[136] S. Huh,et al. Solution structures of the melanocyte-stimulating hormones by two-dimensional NMR spectroscopy and dynamical simulated-annealing calculations. , 1998, European journal of biochemistry.
[137] A. Grüters,et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans , 1998, Nature Genetics.
[138] J. Rees,et al. Melanocortin 1 receptor: what's red got to do with it? , 2001, Journal of the American Academy of Dermatology.
[139] V. Hruby,et al. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. , 1989, Journal of medicinal chemistry.
[140] Shosuke Ito,et al. Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. , 2002, Journal of cell science.
[141] V. Hruby,et al. Design of potent linear α-melanotropin 4-10 analogues modified in positions 5 and 10 , 1989 .
[142] J. Thornton,et al. Analysis and prediction of the different types of β-turn in proteins , 1988 .
[143] Y. Wan,et al. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. , 2001, Biochemistry.
[144] R. Cone,et al. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. , 1995, Journal of medicinal chemistry.
[145] A. Thody,et al. Melanocyte Function and Its Control by Melanocortin Peptides , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[146] J. Shutter,et al. Overexpression of Agrt leads to obesity in transgenic mice , 1997, Nature Genetics.
[147] M. Tota,et al. Molecular determinants of ligand binding to the human melanocortin-4 receptor. , 2000, Biochemistry.
[148] D. Sargent,et al. Preferred conformation, orientation, and accumulation of dynorphin A-(1-13)-tridecapeptide on the surface of neutral lipid membranes. , 1985, Biochemistry.
[149] Stanley J. Watson,et al. A biochemical function for attractin in agouti-induced pigmentation and obesity , 2001, Nature Genetics.
[150] L. Sandkuijl,et al. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. , 2001, American journal of human genetics.
[151] Paolo Grieco,et al. Novel cyclic templates of alpha-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors. , 2002, Journal of medicinal chemistry.
[152] C. Haskell-Luevano,et al. Characterization of aliphatic, cyclic, and aromatic N-terminally "capped" His-D-Phe-Arg-Trp-NH2 tetrapeptides at the melanocortin receptors. , 2003, European journal of pharmacology.
[153] M. Parmentier,et al. Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. , 1994, Biochemistry.
[154] G. Rose,et al. Turns in peptides and proteins. , 1985, Advances in protein chemistry.
[155] L. Akkermans,et al. Effects of Intraduodenal Bile on Interdigestive Gastrointestinal and Gallbladder Motility in Healthy Subjects , 2001, Digestion.
[156] J. Wikberg,et al. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA , 1992, FEBS letters.
[157] M. Low,et al. Receptors for the melanocortin peptides in the central nervous system , 1994 .
[158] Christopher P Austin,et al. A role for the melanocortin 4 receptor in sexual function , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[159] C. Pouton,et al. Synthesis and biological evaluation of α-MSH analogues substituted with alanine , 1994, Peptides.
[160] T. Reisine,et al. Main chain and side chain chiral methylated somatostatin analogs : syntheses and conformational analyses , 1992 .
[161] Potent and selective peptide agonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro. , 2001, Biochemical and biophysical research communications.
[162] Zhimin Xiang,et al. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors. 1. Modifications at the His position. , 2002, Journal of medicinal chemistry.